Full title: Inter-Ewings: International clinical research programme to improve outcomes in newly diagnosed Ewing sarcoma – Trial 1 (INTER-EWING-1)
Age: 2+
Phase: 3
Locations:
- Aberdeen – Royal Aberdeen Children’s Hospital
- Birmingham – Birmingham Children’s Hospital, The Queen Elizabeth Hospital
- Bristol – Bristol Royal Hospital for Children, Bristol Haematology and Oncology Centre
- Cambridge – Addenbrooke’s Hospital
- Edinburgh – Royal Hospital for Children & Young People
- Leeds – St James University Hospital, Leeds General Infirmary
- Leicester – Leicester Royal Infirmary
- London – University College London, Royal Marsden Hospital, Great Ormond Street Hospital for Children
- Liverpool – Alder Hey Children’s Hospital, Clatterbridge Cancer Centre
- Manchester – Christie Hospital, Royal Manchester Children’s Hospital
- Newcastle – Freeman Hospital, Royal Victoria Infirmary
- Oxford – Churchill Hospital, John Radcliffe Hospital
- Sheffield – Sheffield Children’s Hospital, Weston Park Hospital
- Southampton – Southampton General Hospital
- Sutton – Royal Marsden Hospital
Brief summary:
INTER-EWING-1 is an international clinical trial examining several new treatment strategies for Ewing sarcoma patient, including access to a novel agent (a multi tyrosine kinase inhibitor- regorafenib), optimising radiotherapy doses and evaluating the effect of “maintenance” chemotherapy at the end of treatment.
To find out more about this trial and whether you could take part, talk to your clinical team.
